Gareth has over 20 years of experience in working in regulatory, advisory and consultancy roles having spent time working for both the Scottish Government and Energy Consultancies and has developed strong working relationships with industry bodies, key stakeholders and regulators.
Gareth has a wide and in-depth decommissioning experience base having undertaken the planning and support for over 50 decommissioning projects for energy sectors both in the UK and internationally covering floating, fixed platform (both NUI and crewed), derogation and non-derogation assets and subsea systems.
Gareth is the current Chair of the Board of Directors for Decom Mission and is also member of the OEUK Decom Steering Committee and Director of Decom Mission. He is also an alumni of the Future Industries Leadership Programme (FILP) which was an industry and government developed programme driving change within the energy sectors future leadership levels. He also supports the Emerging professional in Late-Life and Decommissioning Group which is helping inspire and support the development of new and transitioning talent into the decommissioning sector.
Chris brings over 25 years of leadership experience in supply chain, operations, procurement, sourcing, contracting, logistics, and alliance collaboration as both a practitioner as well as in an advisory role primarily in the life sciences industry.
Chris currently leads supply chain operations for Upstream Bio and is responsible for establishing supply chain readiness for commercialization of the company’s first product. Prior to Upstream Bio, Chris was the Managing Director of Petilliam Group, a boutique supply chain consultancy advising life sciences companies in all aspects of clinical and commercial supply chain development. Chris also has held various leadership roles at Akebia Therapeutics, Synageva, Alkermes, Transkaryotic Therapies, and Ares Serono.
Chris served on the Board of Directors of the Institute of Supply Management Pharmaceutical Forum for nearly a decade and has shared his experience as a speaker at various local, regional, and international events. He holds an MBA from Boston University and BS from Suffolk University as well as CPSM and Lifetime C.P.M. certification from the Institute of Supply Management, CPIM certification from the Association for Supply Chain Management, and completed executive education programs at Tuck Business School of Dartmouth and MIT Sloan School of Management.
Originally trained as Political Scientist and National Defense Analyst, Peter is a senior pharma business executive and consultant of >20 years. His experience extends boutique and big-four consulting, strategy and tech consulting, inhouse and traditional consulting, as well as C-level positions at Bayer and at GSK. With passion for evidence-based innovation and change, he has created brand, portfolio, and enterprise-wide impact in part by building collaborative platforms and ways of working in Clinical Development, by consolidating supplier relationships in Big Pharma, and by steering and advising teems monitoring therapeutic areas, determining trial timelines and generating congress reporting. Peter has spoken at, and chaired, numerous industry events, in Europe and the U.S., including on data & analytics, on innovation, and on emerging market opportunities. He has a doctorate from the Free University of Berlin (Germany), an MBA from Columbia Business School, and several certificates in Design Thinking (UVA), Strategy (LMU) and AI (Google, Wharton). At GlobalData he’s responsible for the Deallus U.S. consulting team.
Jonathan is a Strategic Advisor at Ab Initio, helping organisations design and run data ecosystems from first principles to create measurable value. With over 35 years in senior technical and transformational leadership roles, he has built durable, scalable capabilities at Experian, Sony PlayStation and Direct Line, spanning data engineering, data science, platform architecture, agile delivery and organisational strategy. A long-time Ab Initio practitioner and former customer for two decades, he has led teams delivering metadata‑driven applications and frameworks that enable adaptive analytics and reliable deployment into single‑customer‑view decisioning. He speaks on the operating disciplines, architectures and leadership needed to turn data platforms and pipelines into valuable outcomes.
Camilla Thoma is a strategic leader in private markets and sustainable investment, serving as CFO and Executive Board Member at Tavis Capital AG, a FINMA‑regulated Swiss asset manager. Her work centers on shaping sophisticated investment strategies across private debt, private equity and alternative structures, with a strong emphasis on building resilient, future‑oriented financial ecosystems.
She is also Chairperson and CEO of MOVEAIR Energy Global AG, where she advances decentralized energy solutions and fosters cross‑industry collaboration in the transition toward climate‑positive technologies.
Known for her ability to connect investors, innovators, and institutional partners, Camilla plays a catalytic role in developing networks that accelerate capital formation and scalable impact. Her perspective blends financial discipline with entrepreneurial vision, making her a sought‑after voice on sustainable finance, emerging investment architectures, and the evolving interplay between technology, capital, and global markets.
Experienced Technology Leader with long track of delivery in the financial services industry across Investment Banking, Asset Management, Wealth Management and Retail. Has had leadership roles in Engineering, Infrastructure and Application Development. Customer focus has lead to development and execution of Strategic road-maps that have increased revenues, merged businesses or divested them with Technology the enabler to the successful outcome. Master of Technology – MTech in Information Technology from Columbia University in the City of York.
